You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • P08.09 Genome-wide CRISPR/Cas9 screening for identification of tumor-intrinsic mechanisms of resistance to anti-PD1 therapy in high-risk neuroblastoma

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
P08 Combination therapy
P08.09 Genome-wide CRISPR/Cas9 screening for identification of tumor-intrinsic mechanisms of resistance to anti-PD1 therapy in high-risk neuroblastoma

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Nagarajan D, Kutkaite G, Tunali G, et al
P08.09 Genome-wide CRISPR/Cas9 screening for identification of tumor-intrinsic mechanisms of resistance to anti-PD1 therapy in high-risk neuroblastoma
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-ITOC9.55